Other OTC • Healthcare • Drug Manufacturers - General • US • USD
Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) has a consensus analyst rating of Buy, based on 8 analysts covering the stock. Of those, 4 recommend buying, 3 recommend holding, and 1 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
